Revolution Medicines Cash Flow Statement
NASDAQ: RVMDHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
189.76+1.64 (+0.87%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Revolution Medicines free cash flow
In fiscal 2025, Revolution Medicines generated -$897.7 million of operating cash flow and spent $16.0 million on capital expenditures. That left free cash flow of -$913.7 million.
Summary generated from market data by MetaCap's automated system. Methodology
Revolution Medicines cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -1.13B | -600.09M | -436.37M | -248.71M | -187.09M | -108.16M | -47.66M | -41.79M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 7.78M | 6.56M | 5.04M | 3.97M | 3.08M | 2.61M | 2.27M | 1.57M |
| Stock-Based Compensation | 118.39M | 79.20M | 61.77M | 31.20M | 20.72M | 8.89M | 3.16M | 855.00K |
| Change in Working Capital | -132.00K | -14.91M | 28.78M | -9.71M | 1.24M | -10.53M | -10.10M | -800.00K |
| Operating Cash Flow | -897.74M | -557.44M | -350.57M | -224.40M | -147.18M | -100.06M | -49.62M | 1.21M |
| Capital Expenditures | -15.99M | -10.31M | -7.73M | -10.82M | -6.53M | -2.93M | -2.59M | -1.50M |
| Investing Cash Flow | 118.06M | -554.39M | -342.60M | -24.12M | -142.12M | -234.23M | -101.97M | -1.34M |
| Dividends Paid | — | — | — | — | — | 0 | — | — |
| Financing Cash Flow | 621.52M | 959.41M | 1.23B | 301.43M | 294.18M | 422.78M | 98.66M | 60.85M |
| Net Change in Cash | -158.16M | -152.42M | 536.03M | 52.91M | 4.88M | 88.48M | -52.93M | 60.72M |
| Free Cash Flow | -913.73M | -567.74M | -358.30M | -235.22M | -153.71M | -103.00M | -52.20M | -286.00K |
This table shows 8 annual periods of Revolution Medicines's cash flow statement, from FY 2025 back to FY 2018, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow RVMD's reporting calendar. What is a cash flow statement?